Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Myriad Genetics (NASDAQ: MYGN) said its management will participate in two investor healthcare conferences in late 2025. Wolfe Research Healthcare Conference — fireside chat on Nov. 18, 2025 at 1:20 pm ET. Piper Sandler Healthcare Conference — fireside chat on Dec. 2, 2025 at 12:00 pm ET. Both presentations will be available via live audio webcasts in the investor information section at investor.myriad.com.
Myriad Genetics (NASDAQ: MYGN) ha comunicato che la sua direzione parteciperà a due conferenze sanitarie per investitori a fine 2025. Wolfe Research Healthcare Conference — colloquio informale il 18 novembre 2025 alle 13:20 ET. Piper Sandler Healthcare Conference — colloquio informale il 2 dicembre 2025 alle 12:00 ET. Entrambe le presentazioni saranno disponibili in diretta tramite webcast audio nella sezione informazioni per gli investitori su investor.myriad.com.
Myriad Genetics (NASDAQ: MYGN) dijo que su dirección participará en dos conferencias de atención médica para inversores a finales de 2025. Conferencia Wolfe Research Healthcare — charla junto a la chimenea el 18 de noviembre de 2025 a las 1:20 p.m. ET. Conferencia Piper Sandler Healthcare — charla junto a la chimenea el 2 de diciembre de 2025 a las 12:00 p.m. ET. Ambas presentaciones estarán disponibles en directo a través de transmisiones de audio en vivo en la sección de información para inversores en investor.myriad.com.
Myriad Genetics (NASDAQ: MYGN)는 경영진이 2025년 말 두 개의 투자자 헬스케어 컨퍼런스에 참여할 예정이라고 발표했습니다. Wolfe Research Healthcare Conference — 2025년 11월 18일 오후 1:20 ET에 fireside chat. Piper Sandler Healthcare Conference — 2025년 12월 2일 오후 12:00 ET에 fireside chat. 두 발표는 투자자 정보 섹션의 라이브 오디오 웹캐스트를 통해 investor.myriad.com에서 시청 가능.
Myriad Genetics (NASDAQ : MYGN) a annoncé que sa direction participera à deux conférences santé pour investisseurs à la fin de 2025. Conférence Santé Wolfe Research — entretien informel le 18 novembre 2025 à 13h20 HE. Conférence Santé Piper Sandler — entretien informel le 2 décembre 2025 à 12h00 HE. Les deux présentations seront disponibles en direct via des webcasts audio dans la section Informations pour les investisseurs sur investor.myriad.com.
Myriad Genetics (NASDAQ: MYGN) hat mitgeteilt, dass das Management an zwei Investorenveranstaltungen im Gesundheitswesen Ende 2025 teilnehmen wird. Wolfe Research Healthcare Conference — Fireside-Chat am 18. November 2025 um 13:20 ET. Piper Sandler Healthcare Conference — Fireside-Chat am 2. Dezember 2025 um 12:00 ET. Beide Präsentationen werden über Live-Audio-Webcasts im Bereich Investor Information unter investor.myriad.com verfügbar sein.
Myriad Genetics (NASDAQ: MYGN) قالت أن الإدارة ستشارك في مؤتمرين للرعاية الصحية للمستثمرين في نهاية 2025. Wolfe Research Healthcare Conference — دردشة بجانب النار في 18 نوفمبر 2025 الساعة 1:20 مساءً بتوقيت شرق الولايات المتحدة. Piper Sandler Healthcare Conference — دردشة بجانب النار في 2 ديسمبر 2025 الساعة 12:00 مساءً بتوقيت شرق الولايات المتحدة. كلا العرضين سيكونان متاحين عبر بث صوتي مباشر في قسم معلومات المستثمرين على investor.myriad.com.
- None.
- None.
SALT LAKE CITY, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences.
- The 7th Annual Wolfe Research Healthcare Conference with a fireside chat on Tuesday, Nov. 18, 2025, at 1:20 pm ET.
- The 37th Annual Piper Sandler Healthcare Conference with a fireside chat on Tuesday, Dec. 2, 2025, at 12:00 pm ET.
The presentations will be available through live audio webcast links in the investor information section of Myriad’s website at investor.myriad.com.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact
Kate Schraml
(224) 875-4493
PR@myriad.com
FAQ
When will Myriad Genetics (MYGN) present at the Wolfe Research Healthcare Conference?
What time is Myriad Genetics (MYGN) scheduled for the Piper Sandler Healthcare Conference?
How can investors watch Myriad Genetics (MYGN) conference presentations?
Are Myriad Genetics (MYGN) conference events live or pre-recorded?
Will Myriad Genetics (MYGN) provide slides or replay for the Nov. 18 and Dec. 2 presentations?
